Skip to main content
SpringerLink
Log in

Skull Base Tumors: Viewpoint—Fractionated Radiotherapy or Stereotactic Radiotherapy

  • Chapter
Principles and Practice of Stereotactic Radiosurgery

  • 2563 Accesses

Abstract

Amongst skull base tumors, chordomas (CHOR), chondrosarcomas (CS), and paragangliomas (PGLs) represent major therapeutic challenges. For CHOR and CS, even maximally safe surgery is followed by a high rate of local recurrence or progression. Thus high-dose, high-precision radiotherapy needs to be given postoperatively, and this is well accomplished by particle therapy. With proton beam radiotherapy (PBT), local control rates are good for CHOR and excellent for CS, with a limited risk of complications. Therefore PBT is often considered to be the standard treatment for these tumors. However postoperative RS and STRT are also able to deliver safely high-dose radiotherapy to CHOR and CS. Results demonstrate that they can yield good to excellent local control rates, and in the absence of PBT they can reasonably be used as alternative therapeutic approaches. In large tumors, where RS may be followed by an increased risk of complications, STRT, which combines the precision of RS and the biological advantage of fractionation, should be preferred. Like for CHOR and CS, a genuine complete resection is rarely possible for PGL, or at the sacrifice of cranial nerves. Conformal, fractionated external beam radiotherapy with moderate-to-high doses is followed by an excellent long-term local control. As PGLs are slow-growing tumors, they shrink also slowly and thus local control after radiotherapy should be defined as the absence of clinical or radiological progression. Results after RS and STRT are also excellent, but like for CHOR and CS, STRT is preferred in case of large tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Prabhu S, Demonte F. Treatment of skull base tumors. Curr Opin Oncol. 2003;15:209–12.

    Article  PubMed  Google Scholar 

  2. Mc Master ML, Goldstein AM, Bromley CM, et al. Chordoma, incidence and survival patterns in the United States. Cancer Causes Control. 2001;12:1–12.

    Article  CAS  Google Scholar 

  3. Yang XR, Ng D, Alcorta DA, et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet. 2009;41:1176–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Sell M, Sampaolo S, Di Lorio G, et al. Chordomas: a histological and immunohistochemical study of cases with or without recurrent tumors. Clin Neuropathol. 2004;23:277–85.

    CAS  PubMed  Google Scholar 

  5. Catton C, O’Sullivan B, Bell R, et al. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol. 1995;41: 67–70.

    Article  Google Scholar 

  6. Almfety K, Pravdenkova S, Coll BO, et al. Chordoma and Chondrosarcoma: similar but quite different, skull base tumors. Cancer. 2007;110:2457–67.

    Google Scholar 

  7. Cianfriglia F, Pompili A, Occhipiati E. Intercranial malignant cartilaginous tumors. Report of 2 cases and review of literature. Act Neurochir. 1978;45:163–75.

    Article  CAS  Google Scholar 

  8. Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery. 1995;36:887–96.

    Article  CAS  PubMed  Google Scholar 

  9. Noel G, Feuvret L, Calugaru V, et al. Chordoma of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3 D conformal technique combining photons and proton beams. Acta Oncol. 2005;44:700–8.

    Article  PubMed  Google Scholar 

  10. Castro JR, Linstadt DE, Bahary JP, et al. Experience in charged particle irradiation of tumors of the skull base: 1977–1992. Int J Radiat Oncol Biol Phys. 1994;29:647–55.

    Article  CAS  PubMed  Google Scholar 

  11. Korten AGC, ter Berg HJW, Spincemaille GH, et al. Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry. 1998;65:88–92.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Debus J, Schulz-Ertner D, Schad L, et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys. 2000;47:591–6.

    Article  CAS  PubMed  Google Scholar 

  13. Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 1999;91:432–9.

    Article  CAS  PubMed  Google Scholar 

  14. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;S2(Suppl):57–63.

    Article  Google Scholar 

  15. Crockard HA, Steel T, Plowman N, et al. A multidisciplinary team approach to skull base chordomas. J Neurosurg. 2001;95: 175–83.

    Article  CAS  PubMed  Google Scholar 

  16. Crockard HA, Cheeseman A, Steel T, et al. A multidisciplinary team approach to skull base chondrosarcomas. J Neurosurg. 2001; 95:184–9.

    Article  CAS  PubMed  Google Scholar 

  17. Koch BB, Karnell LH, Hoffman HT, et al. National Cancer database report on chondrosarcoma of the head and neck. Head Neck. 2000;22:408–25.

    Article  CAS  PubMed  Google Scholar 

  18. Roseberg AE, Nielsen GP, Keel SB, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999;23:1370–8.

    Article  Google Scholar 

  19. Hassounah M, Al-Mefty O, Akhtar M, et al. Primary cranial and intracranial chondrosarcoma. A survey Acta Neurochir. 1985;78: 123–32.

    Article  CAS  PubMed  Google Scholar 

  20. Walcott B, Nahed BV, Mohyeldin A, et al. Chordoma: current concepts, management and future directions. Lancet Oncol. 2012; 13:69–76.

    Article  Google Scholar 

  21. Bloch OG, Jian BJ, Yiang I, et al. A systemic review of intracranial chondrosarcoma and survival. J Clin Neurosciences. 2009;16: 1547–51.

    Article  Google Scholar 

  22. Tzortzidis F, Elali F, Wright D, et al. Patient outcome and long-term follow-up after aggressive microsurgical resection of cranial base chordoma. Neurosurgery. 2006;59:230–7.

    Article  PubMed  Google Scholar 

  23. Krayenbuhl H, Yasargil MG. Cranial chordomas. Prog Neurol Surg. 1975;6:380–434.

    Article  Google Scholar 

  24. Suit HD, Goitein M, Munzenreider J, et al. Definitive radiation therapy for chordoma and chondrosarcoma of the base of skull and cervical spine. J Neurosurg. 1982;56:377–85.

    Article  CAS  PubMed  Google Scholar 

  25. Fagundes MA, Hug EB, Liebsch NJ, et al. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse. Int J Radiat Oncol Biol Phys. 1995;15:579–84.

    Article  Google Scholar 

  26. Potluri S, Jefferies SJ, Jena K, et al. Residual post-operative tumor volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine. Clin Oncol. 2011;23:199–208.

    Article  CAS  Google Scholar 

  27. Igaki H, Tokuuye K, Okumura T, et al. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys. 2004;60:1120–6.

    Article  PubMed  Google Scholar 

  28. Ares C, Hug EB, Lomax AJ, et al. Effectiveness and safety of spot-scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base : first long-term report. Int J Radiat Oncol Biol Phys. 2009;75:1111–8.

    Article  PubMed  Google Scholar 

  29. Schulz-Ertner D, Karger CP, Feuerhake A, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordoma. Int J Radiat Oncol Biol Phys. 2007;68:449–57.

    Article  PubMed  Google Scholar 

  30. Schultz-Ertner D, Nikoghosyan A, Hof H, et al. Carbon ion radiotherapy of skull-base chondrosarcoma. Int J Radiat Oncol Biol Phys. 2007;67:171–7.

    Article  Google Scholar 

  31. Ricken S, Habemehl D, Nikoghosyan A, et al. Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster-scanning technique. Int J Radiat Oncol Biol Phys. 2011;81:793–801.

    Article  Google Scholar 

  32. Martin JJ, Niranjan A, Kondziolka D, et al. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg. 2007; 107:758–69.

    Article  PubMed  Google Scholar 

  33. Krishnan S, Foote RL, Brown PD, et al. Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery. 2005;56:777–83.

    Article  PubMed  Google Scholar 

  34. Feigl GC, Bundschuh O, Gharabaghi A, et al. Evaluation of a new concept for the management of skull base chordomas and chondrosarcomas. J Neurosurg. 2005;S102(Suppl):165–70.

    Article  Google Scholar 

  35. Kocher M, Voges J, Staar S, et al. Linear accelerator radiosurgery for recurrent malignant tumors of the skull base. Am J Clin Oncol. 1998;21:18–22.

    Article  CAS  PubMed  Google Scholar 

  36. Hasegawa T, Ishii D, Kida Y, et al. Gamma- knife surgery for skull-base chordomas and chondrosarcomas. J Neurosurg. 2007;107: 752–7.

    Article  PubMed  Google Scholar 

  37. Bugoci DM, Girvigian MR, Chen JCI, et al. Photon-based fractionated stereotactic radiotherapy for post-operative treatment of skull base chordomas. Am J Clin Oncol 2012; [Epub ahead]

    Google Scholar 

  38. Dassoulas K, Schlesinger D, Yen CP, et al. The role of Gamma-knife surgery in the treatment of skull base chordomas. J Neurooncol. 2009;94:243–8.

    Article  PubMed  Google Scholar 

  39. Kano H, Iqbal F, Sheehan J, et al. Stereotactic radiosurgery for chordoma: a report from the North American Gamma Knife Consortium. Neurosurgery. 2011;68:379–89.

    Article  PubMed  Google Scholar 

  40. Henderson FC, Mc Cool K, Seigle J, et al. Treatment of chordomas with Cyberknife: Geortown University experience and treatment recommendations. Neurosurgery 2009; 64:(2 S) A 44–53

    Google Scholar 

  41. De Lellis RA, Lloyd RV, Heitz PU, et al. World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Lyon,:IARC Press; 2004

    Google Scholar 

  42. Liscak R, Vladyka V, Wowra B, et al. Gamma-knife radiosurgery of the glomus jugulare tumors—early multicentre experience. Acta Neurochir. 1999;141:1141–6.

    Article  CAS  PubMed  Google Scholar 

  43. Eustacchio S, Leber K, Trummer M, et al. Gamma-knife radiosurgery for glomus jugulare tumors. Acta Neurochir. 1999;141: 811–8.

    Article  CAS  PubMed  Google Scholar 

  44. Zabel A, Milker-Zabel S, Huber P, et al. Fractionated stereotactic conformal radiotherapy in the management of large chemodectomas of the skull base. Int J Radiat Oncol Biol Phys. 2004; 58:1445–50.

    Article  PubMed  Google Scholar 

  45. Al-Mefty O, Teixeira A. Complex tumors of the glomus jugulare: criteria, treatment and outcome. J Neurosurg. 2002;97:1256–65.

    Article  Google Scholar 

  46. Fassnacht M, Kreissl MC, Weismann D, et al. New targets and therapeutic approaches for endocrine malignancies. Pharmacol Ther. 2009;123(1):117–41.

    Article  CAS  PubMed  Google Scholar 

  47. Foote RL, Pollok BE, Gorman DA, et al. Glomus jugulare tumors: tumor control and complications after stereotactic radiosurgery. Head Neck. 2002;24:332–9.

    Article  PubMed  Google Scholar 

  48. Pareschi R, Righini S, Destifi D, et al. Surgery of glomus tumors. Skull Base. 2003;13:149–57.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Green JD, Brackmann DE, Nguyen CD, et al. Surgical management of previously untreated glomus jugulare tumors. Laryngoscope. 1994;104:917–21.

    PubMed  Google Scholar 

  50. Fisch U, Fagan P, Valavanis A. The infratemporal fossa approach for the lateral skull base. Otolaryngol Clin North Am. 1984; 17:513–22.

    CAS  PubMed  Google Scholar 

  51. Parenti G, Zampetti B, Rapizzi E, et al. Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. J Oncol 2012 [Epub ahead]

    Google Scholar 

  52. Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J of Clin Endocrinol and Metab. 2001;86:5210–6.

    Article  CAS  Google Scholar 

  53. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002; 346:1459–66.

    Article  CAS  PubMed  Google Scholar 

  54. Bausch B, McWhinney SR. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459–66.

    Article  PubMed  Google Scholar 

  55. Mannelli M, Castellano M, Schiavi F, et al. Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab. 2009;94:1541–7.

    Article  CAS  PubMed  Google Scholar 

  56. Neumann HP, Erlic Z, Boedeker CC, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res. 2009;69:3650–6.

    Article  CAS  PubMed  Google Scholar 

  57. Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genetics. 2012;205:1–11.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res. 2003;63:5615–21.

    CAS  PubMed  Google Scholar 

  59. Welander J. Söderkvist, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Rel Cancer. 2011;18:253–76.

    Article  Google Scholar 

  60. Favier J, Brière J, Burnichon N, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One, 2009;4; 9, e7094,

    Google Scholar 

  61. Califano D, Rizzo C, D’Alessio A, et al. Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells. J Biol Chem. 2000;275:9297–305.

    Article  Google Scholar 

  62. Johannessen CM, Reczek EE, James MF, et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A. 2005;102:8573–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  63. Qin Y, Yao L, King EE, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet. 2010;42: 229–33.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  64. Comino-Méndez I, Gracia-Aznarez FJ, Schiavi F, et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet. 2011;43:663–7.

    Article  PubMed  Google Scholar 

  65. Lenders JWM, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287: 1427–34.

    Article  CAS  PubMed  Google Scholar 

  66. Grossman A, Pacak K, Sawka A, et al. Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann New York Acad Sci. 2006;1073:332–47.

    Article  CAS  Google Scholar 

  67. Davidson FD. Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines. Ann Clin Biochem. 2002;39:557–66.

    Article  CAS  PubMed  Google Scholar 

  68. Van der Harst E, De Herder WW, De Krijger RR, et al. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocr. 2002;147:85–94.

    Article  Google Scholar 

  69. Guignat L, Bidart JM, Nocera M, et al. Chromogranin A and the α-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma. Br J Cancer. 2001;84:808–12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  70. Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. Journal of Clin Endocr Metab. 2004;89:479–91.

    Article  CAS  Google Scholar 

  71. Blake M A, Kalra M K, Maher M M, et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004; 24 (S) S87-S99

    Google Scholar 

  72. Buchmann I, Henze M, Engelbrecht S, et al. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nuc Med Molec Imag. 2007;34:1617–26.

    Article  CAS  Google Scholar 

  73. Nora JD, Hallet JW, O’Brien PC, et al. Surgical resection of carotid body tumors: long-term survival, recurrence and metastasis. Mayo Clin Proc. 1988;63:348–52.

    Article  CAS  PubMed  Google Scholar 

  74. Reddy EK, Mansfield CM, Hartman GV. Chemodectoma of glomus jugulare. Cancer. 1983;52:337–40.

    Article  CAS  PubMed  Google Scholar 

  75. Powell S, Peters N, Harmer C, et al. Chemodectoma of the head and neck: results of treatment in 84 patients. Int J Radiat Oncol Biol Phys. 1992;22:919–24.

    Article  CAS  PubMed  Google Scholar 

  76. Spector GJ, Sobol S. Surgery for glomus tumors at the skull base. Otolaryngol Head Neck Surg. 1980;88:524–30.

    CAS  PubMed  Google Scholar 

  77. Rosenwasser H. Long-term results of therapy of glomus jugulare tumors. Arch Otolaryngol. 1973;97:49–54.

    Article  CAS  PubMed  Google Scholar 

  78. Cole JM, Beiler D. Long-term results of treatment for glomus jugulare and glomus vagale tumors with radiotherapy. Laryngoscope. 1994;104:1461–5.

    CAS  PubMed  Google Scholar 

  79. Konefal JB, Pilepich MV, Spector GJ, et al. Radiation therapy in the treatment of chemodectomas. Laryngoscope. 1987;97:1331–5.

    Article  CAS  PubMed  Google Scholar 

  80. Hinerman RW, Mendenhall WM, Amdar RJ, et al. Definitive radiotherapy in the management of chemodectoma arising in the temporal bone, carotid body and glomus vagale. Head and Neck. 2001; 23:363–71.

    Article  CAS  PubMed  Google Scholar 

  81. Springate SC, Haraf D, Weichselbaum RR. Temporal bone chemodectomas—comparing surgery and radiation therapy. Oncology. 1991;5:131–7.

    CAS  PubMed  Google Scholar 

  82. Huy PT, Kania R, Duet M, et al. Evolving concepts in the management of jugular paraganglioma : a comparison of radiotherapy and surgery in 88 cases. Skull Base. 2009;19(1):83–91.

    Article  PubMed Central  PubMed  Google Scholar 

  83. Lightowlers S, Benedict S, Jefferies SJ, et al. Excellent local control of paraganglioma in the head and neck with fractionated radiotherapy. Clin Oncol. 2010;22:382–9.

    Article  CAS  Google Scholar 

  84. Chino JP, Sampson JH, Tucci DL, et al. Paraganglioma of the head and neck: Long-term local control with radiotherapy. Am J Clin Oncol. 2009;32:304–7.

    Article  PubMed  Google Scholar 

  85. Feigenberg SJ, Mendenhall WM, Hinerman RW, et al. Radiosurgery for paraganglioma of the temporal bone. Head Neck. 2002;24: 384–9.

    Article  PubMed  Google Scholar 

  86. Jordan J, Roland PS, McManus C, et al. Stereotactic radiosurgery for glomus jugulare tumors. Laryngoscope. 2000;110:35–8.

    Article  CAS  PubMed  Google Scholar 

  87. Feigl GC, Horstmann GA. Intracranial glomus jugulare tumors: volume reduction with Gamma Knife surgery. J Neurosurg. 2006; 105:161–7.

    Article  PubMed  Google Scholar 

  88. Ganz JC, Abdelkarim K. Glomus jugulare tumors: certain clinical and radiological aspects observed following Gamma Knife radiosurgery. Acta Neurochir. 2009;151:423–6.

    Article  CAS  PubMed  Google Scholar 

  89. Genç A, Bicer A, Abacioglu U, et al. Gamma Knife radiosurgery for the treatment of glomus jugulare tumors. J Neurooncol. 2010; 97:101–8.

    Article  PubMed  Google Scholar 

  90. Lee CC, Pan DHC, Wu JC, et al. Gamma knife radiosurgery for glomus jugulare and tympanicum. Stereotact Funct Neurosurg. 2011;89:291–8.

    Article  CAS  PubMed  Google Scholar 

  91. Chen PG, Nguyen JH, Payne SC, et al. Treatment of glomus jugulare tumors with gamma knife radiosurgery. Laryngoscope. 2010; 120:1856–62.

    Article  PubMed  Google Scholar 

  92. Lieberson RE, Adler JR, Soltys SG, et al. Stereotactic radiosurgery as the primary treatment for new and recurrent paraganglioma: is open surgical resection still the treatment of choice? World Neurosurg. 2012;77:745–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiation Oncology Department, CHUV, University Hospital Lausanne, Lausanne, Switzerland

    René-O. Mirimanoff M.D.

  2. Clinique de La Source, Vinet Avenue 30, 1004, Lausanne, Switzerland

    René-O. Mirimanoff M.D.

  3. Radiation Oncology Department, CHUV, University Hospital Lausanne, Clinica Luganese, via Moncucco 10, 6900, Lugano, Ticino, Switzerland

    Laura Negretti M.D.

Authors
  1. René-O. Mirimanoff M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Negretti M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to René-O. Mirimanoff M.D. .

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, USA

    Lawrence S. Chin

  2. Dept. of Radiation Oncology, Univ. of Maryland School of Medicine, Baltimore, Maryland, USA

    William F. Regine

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mirimanoff, RO., Negretti, L. (2015). Skull Base Tumors: Viewpoint—Fractionated Radiotherapy or Stereotactic Radiotherapy. In: Chin, L., Regine, W. (eds) Principles and Practice of Stereotactic Radiosurgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8363-2_40

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8363-2_40

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8362-5

  • Online ISBN: 978-1-4614-8363-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation